Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $6.81 and traded as low as $6.56. Coloplast A/S shares last traded at $6.75, with a volume of 364,156 shares changing hands.
Coloplast A/S Stock Down 6.8%
The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The firm has a market capitalization of $15.21 billion, a P/E ratio of 35.53, a P/E/G ratio of 2.56 and a beta of 0.21. The company’s 50-day simple moving average is $6.82 and its two-hundred day simple moving average is $6.81.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%. The business had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.11 billion. As a group, research analysts expect that Coloplast A/S Sponsored ADR will post 0.40 earnings per share for the current year.
Coloplast A/S Company Profile
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
See Also
- Five stocks we like better than Coloplast A/S
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
